|
LSM14B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.723880E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.615900E-04 |
| Normal-vs-Stage2 |
9.387200E-01 |
| Normal-vs-Stage3 |
7.752800E-01 |
| Normal-vs-Stage4 |
5.147800E-01 |
| Stage1-vs-Stage2 |
2.326300E-02 |
| Stage1-vs-Stage3 |
2.981600E-03 |
| Stage1-vs-Stage4 |
4.069900E-02 |
| Stage2-vs-Stage3 |
8.996800E-01 |
| Stage2-vs-Stage4 |
6.701400E-01 |
| Stage3-vs-Stage4 |
6.766400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.219800E-02 |
| Normal-vs-AfricanAmerican |
3.156000E-03 |
| Normal-vs-Asian |
3.415000E-04 |
| Caucasian-vs-AfricanAmerican |
2.059600E-02 |
| Caucasian-vs-Asian |
4.268100E-02 |
| AfricanAmerican-vs-Asian |
3.340600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.829400E-01 |
| Normal-vs-Female |
3.78560000000583E-05 |
| Male-vs-Female |
1.205740E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.217000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.638410E-02 |
| Normal-vs-Age(61-80Yrs) |
2.890000E-02 |
| Normal-vs-Age(81-100Yrs) |
7.689400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.752400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.490800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.305800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.587200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.568420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.058000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.20219999510951E-08 |
| Normal-vs-Grade 2 |
5.996300E-04 |
| Normal-vs-Grade 3 |
4.174200E-01 |
| Normal-vs-Grade 4 |
9.789200E-01 |
| Grade 1-vs-Grade 2 |
8.676900E-03 |
| Grade 1-vs-Grade 3 |
3.93200000000649E-05 |
| Grade 1-vs-Grade 4 |
7.86440000000166E-05 |
| Grade 2-vs-Grade 3 |
4.240500E-03 |
| Grade 2-vs-Grade 4 |
1.103520E-02 |
| Grade 3-vs-Grade 4 |
5.135200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.37709999995062E-06 |
| Normal-vs-ccB subtype |
2.830000E-01 |
| ccA subtype-vs-ccB subtype |
6.77139999627485E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.400200E-02 |
| Normal-vs-N1 |
8.287400E-01 |
| N0-vs-N1 |
6.120000E-01 |
|
|
